2026年2月9日，长风药业股份有限公司（股份代号：02652）刊发翌日披露报表，宣布于同日回购1,500股股份。该回购股份约占回购前已发行股本的0.0005%。
\n\n公告显示，本次回购价格区间为每股35.08港元至35.12港元，涉及总金额约52,650港元。回购完成后，公司已发行股本变更为302,010,086股，同时库藏股数量增至213,500股。公司称，此次回购基于2025年12月16日股东大会通过的购回授权，授权可回购股份总数为30,222,358股，至今已回购213,500股。
\n\n据公告，长风药业确认本次股份回购程序符合香港联合交易所有限公司证券上市规则及相关法律法规。该公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.